British people don’t trust Palantir – it’s not too late to reverse the NHS’s dependence on it | Ben Coleman
A Labour MP and health committee member is calling on UK ministers to let Palantir's £330 million NHS data platform contract expire next March rather than renew it, arguing the NHS should not remain dependent on a US tech company for control of patient data.
Why this matters: This is about who actually controls the health records of roughly 60 million people. Palantir is a US company with deep ties to US intelligence and government agencies. When a foreign private firm runs the infrastructure that holds your most sensitive data, the NHS does not fully own the situation — it owns a contract. Contracts end, get renegotiated, or change terms. Patient data does not get a vote on any of that. The deadline is Christmas. After that, the window to change course gets much smaller.
Who should care: Healthcare professionals · Privacy officers · Compliance
This summary is AI-assisted and may contain errors. It is an original briefing to help you gauge significance quickly — not a reproduction of the source. Always read the linked original before relying on it. See our methodology.